Eszopiclone oral film - IntelGenxAlternative Names: INT 0020/2010; INT-0020
Latest Information Update: 04 Nov 2017
Price : *
At a glance
- Originator IntelGenx Corp.
- Class 2 ring heterocyclic compounds; Esters; Hypnosedatives; Piperazines; Pyrazines; Pyridines; Pyrroles; Sleep disorder therapies; Small molecules
- Mechanism of Action GABA A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Insomnia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Insomnia in Canada (PO, Film)
- 29 Apr 2016 Biomarkers information updated
- 27 Feb 2014 Development of eszopiclone oral film is ongoing in Insomnia